NDC 49281-860

IPOL

Poliovirus Type 1 Antigen (formaldehyde Inactivated), Poliovirus Type 2 Antigen (formaldehyde Inactivated), And Poliovirus Type 3 Antigen (formaldehyde Inactivated)

IPOL is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Poliovirus Type 1 Antigen (formaldehyde Inactivated); Poliovirus Type 2 Antigen (formaldehyde Inactivated); Poliovirus Type 3 Antigen (formaldehyde Inactivated).

• Product ID: 49281-860_0dfd3fb5-e588-4d7a-a272-398702d52990
• NDC: 49281-860
• Product Type: Vaccine
• Proprietary Name: IPOL
• Generic Name: Poliovirus Type 1 Antigen (formaldehyde Inactivated), Poliovirus Type 2 Antigen (formaldehyde Inactivated), And Poliovirus Type 3 Antigen (formaldehyde Inactivated)
• Dosage Form: Injection, Suspension
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 1990-12-21
• Marketing Category: BLA / BLA
• Application Number: BLA103930
• Labeler Name: Sanofi Pasteur Inc.
• Substance Name: POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
• Active Ingredient Strength: 40 [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL
• Pharm Classes: Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 49281-860-10

1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) > 5 mL in 1 VIAL, MULTI-DOSE (49281-860-78)

• Marketing Start Date: 1990-12-21
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49281-860-10 [49281086010]

IPOL INJECTION, SUSPENSION

• Marketing Category: BLA
• Application Number: BLA103930
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 1990-12-21

NDC 49281-860-88 [49281086088]

IPOL INJECTION, SUSPENSION

• Marketing Category: BLA
• Application Number: BLA103930
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 2014-02-26
• Marketing End Date: 2015-09-11

NDC 49281-860-55 [49281086055]

IPOL INJECTION, SUSPENSION

• Marketing Category: BLA
• Application Number: BLA103930
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 1990-12-21
• Marketing End Date: 2015-09-11

NDC 49281-860-78 [49281086078]

IPOL INJECTION, SUSPENSION

• Marketing Category: BLA
• Application Number: BLA103930
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 2014-02-26

Drug Details

Active Ingredients

Ingredient	Strength
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)	40 [D'ag'U]/.5mL

Pharmacological Class

• Inactivated Poliovirus Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Poliovirus Vaccines [CS]
• Vaccines
• Inactivated [CS]
• Inactivated Poliovirus Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Poliovirus Vaccines [CS]
• Vaccines
• Inactivated [CS]
• Inactivated Poliovirus Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Poliovirus Vaccines [CS]
• Vaccines
• Inactivated [CS]

NDC Crossover Matching brand name "IPOL" or generic name "Poliovirus Type 1 Antigen (formaldehyde Inactivated), Poliovirus Type 2 Antigen (formaldehyde Inactivated), And Poliovirus Type 3 Antigen (formaldehyde Inactivated)"

NDC	Brand Name	Generic Name
49281-860	IPOL	POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
50090-1693	IPOL	POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)